Edward Bastow

Edward Bastow is a Researcher affiliated with the UWA Medical School and the UWA Centre for Medical Research (affiliated with the Harry Perkins Institute of Medical Research). His primary research focuses on cancer immunotherapy, tumor microenvironment dynamics, and pericyte biology. He investigates how pericyte phenotype switching impacts immunosuppression and enhances anti-cancer immunity, with applications in drug development for vascularized tumors. His work contributes to UN Sustainable Development Goal 3 (Good Health and Well-Being).

Recent research highlights include studies on tubulin-binding drugs' effects on pericytes, immune priming in humanized mouse models, and mechanisms of immunotherapy resistance. These studies emphasize translational approaches targeting tumor-associated immunosuppression.

• Affiliations: UWA Medical School, UWA Centre for Medical Research, Harry Perkins Institute of Medical Research
• Key Projects: Pericyte-driven anti-tumor immunity, drug repurposing for cancer therapy, preclinical model development
• Collaborations: International teams in oncology, immunology, and drug discovery

His publications (2024–2025) demonstrate interdisciplinary approaches combining immunology, pharmacology, and cancer biology to advance therapeutic strategies. No formal student advisees or named grants are listed in the provided materials.